Listen "PKU And Ageing"
Episode Synopsis
Dr Emma Vardy, a Consultant Geriatrician from Salford, UK, explains the findings of a recent JIMD review looking at the impact of phenylketonuria in adulthood. With those who have benefitted from early treatment now approaching their fifth and sixth decades, PKU cannot just be seen as a disease of childhood and more work is needed to look into the long term impact of the condition.
Phenylketonuria, co‐morbidity, and ageing: A review
Emma R.L.C. Vardy, Anita MacDonald, Suzanne Ford, Denise L. Hofman
https://doi.org/10.1002/jimd.12186
Phenylketonuria, co‐morbidity, and ageing: A review
Emma R.L.C. Vardy, Anita MacDonald, Suzanne Ford, Denise L. Hofman
https://doi.org/10.1002/jimd.12186
More episodes of the podcast JIMD Podcasts
Shortcast: Liver Directed Rx don’t change biochemistry nor Leukodystrophy in Biallelic HMBS Variants
30/12/2025
Sixty Years of Metabolic Medicine: A Conversation with Jean-Marie Saudubray and Manuel Schiff
23/12/2025
Shortcast: Exploratory Study on the Challenges of Newborn Screening for Lysosomal Storage Disorders
25/11/2025
IMD Research Round-Up: Mitochondrial disease
11/11/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.